$OKUR SEC Filings

Filed On	Filing
07 Oct 2026	SCHEDULE 13G
23 Sep 2026	Form 4: Leverone Jason A., Chief Financial Officer Sold 302 shares ($898)
23 Sep 2026	Form 4: Saccomano Nicholas A, Director Sold 87 shares ($259)
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
13 Aug 2026	Form 4/A: Manke Isaac, Director Holds 15,300 Stock Option (right to buy) (exercise price $18.20, expires Oct 3, 2034)
13 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation
11 Aug 2026	Form 4: Mathers Edward T, Director Granted 22,350 Stock Option (right to buy)
11 Aug 2026	Form 4: Ratcliffe Liam, Director Granted 22,350 Stock Option (right to buy)
11 Aug 2026	Form 4: Phillips Andrew John, Director Granted 22,350 Stock Option (right to buy)
11 Aug 2026	Form 4: Manke Isaac, Director Granted 315,300 Stock Option (right to buy) · Disposed of 15,300 Stock Option (right to buy) (Disposition to Issuer)
11 Aug 2026	Form 4: Jansen Valerie Malyvanh, Director Granted 22,350 Stock Option (right to buy)
11 Aug 2026	Form 4: Grey Michael G, Director Granted 22,350 Stock Option (right to buy)
11 Aug 2026	Form 4: Carruthers R Michael, Director Granted 22,350 Stock Option (right to buy)
11 Aug 2026	Form 4: Saccomano Nicholas A, Director Granted 721,423 Employee Stock Option (right to buy) · Disposed of 571,423 Employee Stock Option (right to buy) (Disposition to Issuer)
11 Aug 2026	Form 4: Leverone Jason A., Chief Financial Officer Granted 185,933 Employee Stock Option (right to buy) · Disposed of 5,781 Employee Stock Option (right to buy (Disposition to Issuer) · Granted 5,781 Employee Stock Option (right to buy · 1 more
11 Aug 2026	Form 4: Hartley Dylan, Chief Scientific Officer Granted 187,603 Employee Stock Option (right to buy) · Disposed of 137,603 Employee Stock Option (right to buy) (Disposition to Issuer)
11 Aug 2026	Form 4: Agresta Samuel, Chief Medical Officer Granted 199,984 Employee Stock Option (right to buy) · Disposed of 149,984 Employee Stock Option (right to buy) (Disposition to Issuer)
10 Aug 2026	SCHEDULE 13G/A

Comments